Clik here to view.
武田宣布，《临床肿瘤学杂志》发表ALUNBRIG™ (brigatinib)枢纽性2期ALTA临床试验的数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，《临床肿瘤学杂志》发表枢纽性2期ALTA (ALK in Lung Cancer Trial of AP26113)临床试验的数据(DOI: 10.1200/JCO.2016.71.5904 Journal of Clinical Oncology)，该试验评估ALUNBRIG™...
View ArticleClik here to view.
Medrobotics® Corporation Announces TGA Clearance for Flex® Robotic System for...
RAYNHAM, Mass. Medrobotics Corp., a medical robotics company, announced today at the Royal Australasian College of Surgeons meeting in Adelaide that it has received TGA regulatory clearance to...
View ArticleClik here to view.
Avita Medical Initiates Legal Proceedings to Cancel Renovacare Patent
VALENCIA, Calif. & PERTH, Australia & CAMBRIDGE, England Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects,...
View ArticleClik here to view.
武田公布2016财年全年业绩，更新2017财年展望
日本大阪 (美国商业资讯)–武田药品工业株式会社(Takeda Pharmaceutical Company Limited)(TOKYO: 4502)： 盈利较去年有大幅增长...
View ArticleClik here to view.
Hoya Reports Fourth Quarter and Full-Year Financial Results
TOKYO HOYA Corporation (TOKYO:7741) today announced financial results for the fourth quarter and full-year ended March 31, 2017. During the quarter, revenues increased 3.8% year on year, reaching...
View ArticleClik here to view.
Kristin Neuman将在NewYorkBIO和AIPLA上谈论MPEG LA的CRISPR专利池许可证
丹佛 (美国商业资讯)–全球许可领导者MPEG LA, LLC今天宣布，MPEG LA的生物技术许可执行总监Kristin Neuman将在NewYorkBIO和美国知识产权法协会(AIPLA)春季会议上发表演讲，这两项活动将分别于5月11日和5月17日在纽约市和圣地亚哥举行。届时，Neuman女士将探讨MPEG LA的CRISPR-Cas9联合许可平台(Joint Licensing...
View ArticleClik here to view.
クリスティン・ニューマンがNewYorkBIOとAIPLAでMPEG LAのCRISPRプールライセンスについて発題
デンバー （ビジネスワイヤ） — ライセンシングの世界的リーダー企業MPEG LAは本日、MPEG...
View ArticleClik here to view.
武田薬品、ALUNBRIG™（ブリガチニブ）のピボタル第2相ALTA臨床試験のデータがジャーナル・オブ・クリニカル・オンコロジーに掲載と発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE: 4502)は本日、クリゾチニブ抵抗性で未分化リンパ腫キナーゼ陽性（ALK+）の局所進行性／転移性非小細胞肺がん（NSCLC）患者でALUNBRIG™（ブリガチニブ）を評価するピボタル第2相ALTA（ALK in Lung Cancer Trial of...
View ArticleClik here to view.
Boehringer Ingelheim strengthens early science portfolio through...
INGELHEIM, Germany & BEIJING, China Boehringer Ingelheim and Peking University (PKU) today announced an ambitious strategic partnership with the aim of jointly advancing early science innovation...
View ArticleClik here to view.
CANbridge and AmoyDx Enter into Strategic Partnership for CAN008 Companion...
BEIJING CANbridge Life Sciences and Amoy Diagnostics announced that they have entered into a strategic partnership to develop a companion diagnostic assay for CANbridge’s lead candidate, CAN008, a...
View ArticleClik here to view.
Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients...
MILAN & MORRISTOWN, N.J. Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces USFDA Approval for the Launch of...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received approval from the U.S. Food and Drug Administration...
View ArticleClik here to view.
Avita Medical Announces Positive Results from Pivotal Trial
VALENCIA, Calif. & PERTH, Australia Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today said it achieved both...
View ArticleClik here to view.
Chi-Med Presents Clinical Data at ASCO 2017 Annual Meeting
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that new clinical data on three of its novel tyrosine kinase inhibitors, fruquintinib, savolitinib and...
View ArticleClik here to view.
Company Profile for Laurus Labs Limited
Laurus is a leading research and development driven pharmaceutical company in India. The Company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical...
View ArticleClik here to view.
ClearSight Announces Sale of Parent Company, Sharklet Technologies
AURORA, Colo. ClearSight LLC is pleased to announce the acquisition of its parent company Sharklet Technologies, Inc., by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight...
View ArticleClik here to view.
CANbridge Life Sciences Raises $25 Million in Series B Round Led by Lapam...
BEIJING CANbridge Life Sciences, a clinical-stage biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that it raised $25 million in a Series B...
View ArticleClik here to view.
Dompé Receives Positive CHMP Opinion in Europe For Oxervate® (Cenegermin Eye...
MILAN Today, the biopharmaceutical company Dompé has announced that the Committee for Human Medicinal Products (CHMP) of EMA (European Medicines Agency) has released a positive opinion, recommending...
View ArticleClik here to view.
Upside Biotechnologies to Work with US Army on Engineered Skin Replacement
AUCKLAND, New Zealand Regenerative medicine start-up Upside Biotechnologies has signed a CRADA (Cooperative Research and Development Agreement) with the US Army Medical Research and Materiel Command...
View ArticleClik here to view.
GORE® EXCLUDER® Iliac Branch Endoprosthesis Approved in Japan
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) announced the first implants in Japan of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE). Gore has received Shonin approval from the...
View Article